Screener
Harmony Biosciences Holdings, Inc. HRMY Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Income tax expense | (7,199) | (11,617) |
| Net income | $32,488 | $45,560 |
| Unrealized (loss) income on investments | (759) | 179 |
| Comprehensive income | $31,729 | $45,739 |
| EARNINGS PER SHARE: | ||
| Basic | $0.56 | $0.79 |
| Diluted | $0.55 | $0.78 |
| Weighted average number of shares of common stock - basic | 57,819,060 | 57,309,938 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Harmony Biosciences Holdings, Inc. (HRMY) reported comprehensive income (loss), net of tax, attributable to parent of $31.73M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 30.6% year-over-year, from $45.74M to $31.73M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 46.4% compound annual growth rate (CAGR), from $34.6M to $158.97M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric reflects the total change in equity from non-owner sources, encompassing net income and other gains or losses that are not yet realized or recognized in the standard income statement. It serves as a comprehensive measure of the company's financial performance by accounting for items like foreign currency translation adjustments or unrealized gains on securities. Monitoring this figure helps investors understand the broader economic impact on shareholder value beyond traditional operating profitability.
Ask your AI about Harmony Biosciences Holdings, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude